Basel, Switzerland

Heike Maria Strobel

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Zurich, CH (2019)
  • Basel, CH (2020)

Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Heike Maria Strobel: Innovator in Recombinant Binding Proteins

Introduction

Heike Maria Strobel, an accomplished inventor based in Basel, Switzerland, has made significant contributions to the field of biotechnology. With a focus on recombinant binding proteins, her innovations have the potential to advance treatments for various diseases. She holds two patents that underscore her expertise and dedication to her field.

Latest Patents

Heike Maria Strobel's latest patents include "Recombinant Binding Proteins Targeting HER2 and Serum Albumin, and Their Uses." This innovative patent encompasses new recombinant binding proteins that feature designed ankyrin repeat domains. These proteins show specificity for HER2 and serum albumin, along with the nucleic acids that encode them. Furthermore, the patent includes pharmaceutical compositions that leverage these recombinant binding proteins or nucleic acids in treating diseases.

Another notable patent is "Binding Proteins Comprising at Least Two Repeat Domains Against HER2." This invention focuses on a recombinant binding protein that comprises a first and a second repeat domain, each binding to the extracellular region of HER2. Importantly, these repeat domains are covalently linked, enhancing their functionality in therapeutic applications.

Career Highlights

Heike Maria Strobel works at Molecular Partners AG, a pioneering company that specializes in the development of innovative therapeutic proteins. Her role in this organization places her at the forefront of biotechnological advancements, contributing to crucial research in treating complex diseases.

Collaborations

Throughout her career, Heike has collaborated with talented colleagues, including Ulrike Fiedler and Ignacio Dolado. These partnerships reflect the collaborative spirit prevalent in innovative research environments, allowing for the exchange of ideas and expertise that drive breakthrough advancements.

Conclusion

Heike Maria Strobel exemplifies the essence of innovation in biotechnology. Her patents demonstrate a clear commitment to improving healthcare through her work on recombinant binding proteins. As she continues her research at Molecular Partners AG, the implications of her inventions are likely to have a lasting impact in the fight against diseases, showcasing the importance of inventors in the advancement of science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…